Laura Toppo

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

Lorenza Rimassa, Silvia Bozzarelli, Filippo Pietrantonio et al. · Clinical Colorectal Cancer · 2019 · 51 citations

Oncology, Acquired Resistance, Medicine +7

Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia

Patrizia Caporaso, Mario Turriziani, Adriano Venditti et al. · DNA repair · 2007 · 20 citations

Hematological Malignancy, Acute Leukaemia, Medicine +13

Ramucirumab for Metastatic Gastric or Gastroesophageal Junction Cancer: Results and Implications of the REGARD Trial

Wanda Liguigli, Gianluca Tomasello, Laura Toppo et al. · Future Oncology · 2014 · 11 citations

Surgical Oncology, Esophageal Cancer, Immunology +16

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)

Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro et al. · Current Oncology · 2021 · 10 citations · Full text